31 related articles for article (PubMed ID: 21319993)
1. A commentary on "Identification and initial validation of maximal tumor area as a novel prognostic factor for overall and disease-free survival in patients with resectable colon cancer: a retrospective study".
Deng L; Cheng W; Liu W
Int J Surg; 2024 Mar; ():. PubMed ID: 38498391
[No Abstract] [Full Text] [Related]
2. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma.
Xie T; Hou D; Wang J; Zhao S
Front Pediatr; 2023; 11():904730. PubMed ID: 37124183
[TBL] [Abstract][Full Text] [Related]
3. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF CHILDREN WITH NEUROBLASTOMA: 21 YEARS OF EXPERIENCE AT THE INSTITUTO DE ONCOLOGIA PEDIÁTRICA, IN SÃO PAULO, BRAZIL.
Lucena JN; Alves MTS; Abib SCV; Souza GO; Neves RPC; Caran EMM
Rev Paul Pediatr; 2018; 36(3):254-260. PubMed ID: 29995142
[TBL] [Abstract][Full Text] [Related]
4. Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.
Pezzolo A; Rossi E; Gimelli S; Parodi F; Negri F; Conte M; Pistorio A; Sementa A; Pistoia V; Zuffardi O; Gambini C
Neuro Oncol; 2009 Apr; 11(2):192-200. PubMed ID: 18923191
[TBL] [Abstract][Full Text] [Related]
5. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
7. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
[TBL] [Abstract][Full Text] [Related]
8. Overall genomic pattern is a predictor of outcome in neuroblastoma.
Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.
Parodi F; Passoni L; Massimo L; Luksch R; Gambini C; Rossi E; Zuffardi O; Pistoia V; Pezzolo A
OMICS; 2011 Mar; 15(3):113-21. PubMed ID: 21319993
[TBL] [Abstract][Full Text] [Related]
10. Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma.
Mora J; Gerald WL; Cheung NK
Cancer Lett; 2003 Jul; 197(1-2):119-24. PubMed ID: 12880970
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of peripheral neuroblastic tumors.
Janoueix-Lerosey I; Schleiermacher G; Delattre O
Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
